Coimmunoprecipitation of CRBN

AR Aline Renneville
JG Jessica A. Gasser
DG Daniel E. Grinshpun
PB Pierre M. Jean Beltran
NU Namrata D. Udeshi
MM Mary E. Matyskiela
TC Thomas Clayton
MM Marie McConkey
KV Kaushik Viswanathan
AT Alexander Tepper
AG Andrew A. Guirguis
RS Rob S. Sellar
SC Sophie Cotteret
CM Christophe Marzac
VS Véronique Saada
SB Stéphane De Botton
JK Jean-Jacques Kiladjian
JC Jean-Michel Cayuela
MR Mark Rolfe
PC Philip P. Chamberlain
SC Steven A. Carr
BE Benjamin L. Ebert
ask Ask a question
Favorite

3 × 106 wild-type Hep3B cells were plated onto 15-cm dishes and transfected with 35 μg empty vector or pLX304-ZMYM2, which encodes ZMYM2-V5. Cells were treated with DMSO or 20 μmol/L avadomide in the presence of 10 μmol/L MG-132 for the last 3 hours before harvest. Cells were harvested 48 hours posttransfection and lysed in lysis buffer (as described above) containing 20 μmol/L avadomide or DMSO. Whole-cell extracts were cleared by centrifugation at 13,000 × g at 4°C for 15 minutes, normalized, and incubated with anti–V5-tag magnetic beads (MBL International) at 4°C for 16 hours. After washing the beads three times in wash buffer (150 mmol/L NaCl, 50 mmol/L Tris-HCl pH 8.0, 1% glycerol, 1× Halt Protease, and Phosphatase Inhibitor Cocktail) containing 20 μmol/L avadomide or DMSO, anti-V5 immunoprecipitates were eluted by boiling in Laemmli SDS sample buffer at 95°C for 5 minutes and then subjected to immunoblot analysis for CRBN.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A